Gruppo Lepetit Company Profile
✉ Email this page to a colleague
What is the competitive landscape for GRUPPO LEPETIT, and what generic and branded alternatives to GRUPPO LEPETIT drugs are available?
GRUPPO LEPETIT has one approved drug.
Summary for Gruppo Lepetit
| US Patents: | 0 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for Gruppo Lepetit
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gruppo Lepetit | CHLORAMPHENICOL SODIUM SUCCINATE | chloramphenicol sodium succinate | INJECTABLE;INJECTION | 062278-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
